Elderly Patients with Hepatocellular Carcinoma benefit from Liver Transplantation as much as younger ones
Abstract: Introduction: The literature on liver transplantation (LT) for cirrhosis-associated hepatocellular carcinoma (cirr-HCC) in elderly patients (≥65 years of age) is scarce. The aim of this study was therefore to analyze the outcome after LT for cirr-HCC in elderly patients in our single-cente...
Main Authors: | Jens Mittler, Stefan Heinrich, Martina Koch, Maria Hoppe-Lotichius, Ali Hadian, Arndt Weinmann, Roman Kloeckner, Peter Robert. Galle, Hauke Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-12-01
|
Series: | Liver Cancer |
Online Access: | https://www.karger.com/Article/FullText/528830 |
Similar Items
-
Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
by: Lea Penzkofer, et al.
Published: (2023-01-01) -
Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
by: Fabian Bartsch, et al.
Published: (2019-10-01) -
Surgical therapy of primary hepatic angiosarcoma
by: Verena Tripke, et al.
Published: (2019-01-01) -
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates
by: Lukas Müller, et al.
Published: (2023-04-01) -
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy
by: Lukas Müller, et al.
Published: (2022-07-01)